Pharmaron Beijing Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Beijing, Beijing and currently employs 21,370 full-time employees. The company went IPO on 2019-01-28. Pharmaron Beijing Co Ltd is a China-based company mainly engaged in pharmaceutical research and development. The firm operates through five segments. The Laboratory Services segment includes laboratory chemistry and bioscience services, covering small molecule drugs, oligonucleotides, peptides, antibodies, antibody-drug conjugates, and cell and gene therapy products. The Chemical and Formulation Process Development and Manufacturing Services segment includes active pharmaceutical ingredient process development and manufacturing, as well as preformulation and formulation development. The Clinical Research Services segment includes international and domestic clinical research services. The Large Molecule and Cell and Gene Therapy Services segment includes large molecule drug discovery, development, and manufacturing services, as well as cell and gene therapy laboratory and gene therapy drug development and manufacturing services. The firm also operates through the others segment.
Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Hasılat
13,544
12,275
11,537
10,266
7,443
5,133
Hasılat Artışı (YoY)
15%
6%
12%
38%
45%
37%
Satınalma Maliyeti
9,011
8,091
7,422
6,501
4,767
3,214
Brüt Kâr
4,532
4,184
4,115
3,764
2,676
1,918
Satış, Genel ve İdari
1,998
1,772
1,766
1,640
977
720
Araştırma ve Geliştirme
528
432
418
261
135
91
İşletme Giderleri
2,528
2,385
2,330
2,041
1,165
832
Diğer Finansman Gelirleri (Giderleri)
-22
-4
-10
-23
-3
-4
Kâr Öncesi Gelir
1,798
2,091
1,837
1,666
1,910
1,319
Kira Vergisi Gideri
387
377
256
314
290
172
Net Kâr
1,512
1,793
1,601
1,374
1,661
1,172
Net Income Growth
Kâr Artışı
-20%
12%
17%
-17%
42%
113.99%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
1,763.38
1,773.31
1,772.52
1,776.27
1,819.77
793.2
Hisse Değişimi (Yıllık Üst Üste)
0%
0%
0%
-2%
129%
20%
EPS (Diluted)
0.85
1.01
0.9
0.77
0.91
1.48
EPS Artışı
-19%
12%
17%
-15%
-38%
78%
Öz sermaye akışı
800
536
-111
-807
-34
332
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
33.46%
34.08%
35.66%
36.66%
35.95%
37.36%
Faaliyet Kâr Marjı
14.78%
14.64%
15.47%
16.77%
20.28%
21.15%
Kâr Marjı
11.16%
14.6%
13.87%
13.38%
22.31%
22.83%
Özsermaye Karlılık Oranı
5.9%
4.36%
-0.96%
-7.86%
-0.45%
6.46%
EBITDA
--
2,058
2,025
1,917
1,625
1,173
EBITDA Marjinali
--
16.76%
17.55%
18.67%
21.83%
22.85%
D&A EBITDA için
--
260
240
195
115
87
Faaliyet Kârı
2,003
1,798
1,785
1,722
1,510
1,086
Faaliyet Kâr Marjı
14.78%
14.64%
15.47%
16.77%
20.28%
21.15%
Verilen Vergi Oranı
21.52%
18.02%
13.93%
18.84%
15.18%
13.04%
Follow-Up Questions
Pharmaron Beijing Co., Ltd.'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, Pharmaron Beijing Co., Ltd.'in toplam varlıkları $23,927 olup, net kâr $1,793'dir.
PHBBF'ün temel finansal oranları nelerdir?
Pharmaron Beijing Co., Ltd.'in cari oranı 2.32, net kâr marjı 14.6, hisse başına satış $6.92'dir.
Pharmaron Beijing Co., Ltd.'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Pharmaron Beijing Co., Ltd. en büyük gelir kaynağı Laboratory Services olup, en son kar bildiriminde geliri 7,046,874,518 dir. Coğrafi olarak, North America , Pharmaron Beijing Co., Ltd. için ana pazar olup, geliri 7,852,729,440 dir.
Pharmaron Beijing Co., Ltd. kârlı mı?
evet, son mali tablolara göre Pharmaron Beijing Co., Ltd.'in net kâr $1,793'dir.
Pharmaron Beijing Co., Ltd.'in herhangi bir yükümlülüğü var mı?